comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-01 22:48:56 - browse：8711

Katie Palmer, STAT (left) moderating the Doctor vs. ChatGPT session during the 2023 STAT Summit. STAT

Generative AI tools are already helping doctors transcribe visits and summarize patient records. The technology behind ChatGPT, trained on vast amounts of data from the internet, made headlines when it correctly answered more than 80% of board exam questions. In July, a team at Beth Israel saw promising results when using GPT-4 during a diagnosis workshop for medical residents.

But the tool is by no means ready for primetime. When given questions about real-life medical scenarios by Stanford researchers, GPT frequently disagreed with humans or offered irrelevant information. The AI models are prone to “hallucinating,” or making things up because they sound right — a tendency that could cause immeasurable harm if let loose on patients. AI leaders and policymakers alike have called for more regulations.

STAT decided to put ChatGPT to the test at its annual summit on Wednesday, pitting the tool against Ann Woolley, infectious disease specialist at Brigham and Women’s Hospital. Marc Succi, the associate innovation chair at Mass General Brigham, gave two patient scenarios to the tool while Woolley explained her own diagnoses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： President Biden's budget: Here's what you might have missed

WSS

Amid AI frenzy, a top HHS official's quest to create safeguards

FDA sets aggressive timeline for overhauling inspection procedures

Readout Newsletter: CAR

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

As AI in medicine takes off, can 'human in the loop' prevent harm?

Medicare coverage of Wegovy, once blocked, now looks possible

Wikipedia

comprehensive

focus

At least 13 dead in Texas as scorching temps continue

Inaction leaves children at risk from dangerous chemotherapy drug

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Medical records are filled with copy

How to save health care price transparency rules

Medicare details structure of new drug price negotiation program

Flu vaccine reformulation won't be easy, manufacturers warn

Apple is now the first public company to be valued at $3 trillion

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

hotspot

The inclusion problem at the heart of rehabilitation research

How many hemophilia patients actually want gene therapy?

Head of FDA's diagnostics center, who led through Covid, retires

Immunocompromised patients offer clues on chronic Covid

EPA limits use of carcinogenic gas for sterilizing medical devices

The inclusion problem at the heart of rehabilitation research

hotspot

entertainment

hotspot

hotspot